SPONSOR
University of Oklahoma
Total Trials
15
Recruiting
15
Phases
Phase 2, Phase 1, Phase 4, Phase 3
Conditions studied: CRC ScreeningCRC (Colorectal Cancer)Alcohol DrinkingHeavy DrinkingBinge DrinkingCigarette SmokingAndrogen Deprivation TherapyLocally Advanced Prostate CancerOlderAdults
University of Oklahoma is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including CRC Screening, CRC (Colorectal Cancer), Alcohol Drinking, Heavy Drinking.
The trial portfolio spans Phase 2, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Oklahoma
How many clinical trials has University of Oklahoma sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by University of Oklahoma, of which 15 are actively recruiting participants. These trials cover conditions including CRC Screening, CRC (Colorectal Cancer), Alcohol Drinking. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Oklahoma research focus on?
University of Oklahoma clinical trials span CRC Screening, CRC (Colorectal Cancer), Alcohol Drinking, Heavy Drinking, Binge Drinking, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Oklahoma clinical trial?
To participate in a University of Oklahoma trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Oklahoma trials with current recruitment status updated daily.
Clinical Trials by University of Oklahoma
NCT07254910
Recruiting
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
CRC Screening
NCT07591428
Recruiting
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
Alcohol Drinking
NCT05233228 Phase 2
Recruiting
Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
Cigarette Smoking
NCT06130995 Phase 1
Recruiting
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Androgen Deprivation Therapy
NCT07554118
Recruiting
Postural Control in Adults
Older
NCT05723081
Recruiting
Oklahoma Study of Native American Pain Risk III: Stress and Resilience
Discrimination, Racial
NCT06725953
Recruiting
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 Diabetes
Cancer Survivorship
NCT07701304
Recruiting
Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment
Cannabis Use
NCT05052671
Recruiting
ctDNA Assay in Patients With Resectable Pancreatic Cancer
Pancreas Cancer
NCT07223541 Phase 2
Recruiting
Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
NCT06651359
Recruiting
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Prostate Cancer
NCT07014618
Recruiting
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Breast Cancer
NCT05176379 Phase 4
Recruiting
Endothelial Derived Hyperpolarization Factor and Vascular Control
Healthy
NCT04459000
Recruiting
Substance Use Treatment and Access to Resources (STARS) Project
Substance Use Disorders
NCT05174052 Phase 3
Recruiting
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
Diabetes Mellitus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology